Who Buys Torsemide from India — 232 Importers Behind a $18.2M Market

The importers of Torsemide from India can be categorized into several key segments:

1. Distributors: These entities purchase large quantities of Torsemide to supply to various healthcare providers, pharmacies, and retailers within their respective countries. For instance, MICRO NOVA PHARMACEUTICALS IND in Nigeria, which imported Torsemide worth $1.12 million, likely operates as a distributor, ensuring widespread availability of the medication across the Nigerian market.

2. Contract Manufacturers: Companies that import Torsemide for the purpose of further manufacturing or repackaging before distribution. AUROLOGISTICS LLC, associated with AUROBINDO PHARMA in the United States, appears multiple times among the top buyers, with combined imports totaling approximately $2.57 million. This suggests a role in contract manufacturing or distribution within the U.S. pharmaceutical supply chain.

3. Retail Chains and Hospital Groups: While specific data on retail chains and hospital groups is not detailed in the provided information, it's common for such entities to import pharmaceuticals directly to meet the needs of their patients and customers.

4. Government Procurement Agencies: These agencies import medications to supply public healthcare facilities. The data does not specify any government procurement agencies among the top buyers of Torsemide from India.

5. Re-exporters: Companies that import pharmaceuticals with the intention of exporting them to other markets. The data does not provide specific information on re-exporters in the context of Torsemide imports.

Each segment exhibits distinct purchasing behaviors. Distributors and contract manufacturers often place large, recurring orders to maintain a steady supply chain, as evidenced by the 64.2% repeat buyer rate among the 232 buyers. Retail chains and hospital groups may order based on patient demand and inventory levels, leading to variable order sizes and frequencies. Government agencies typically procure through tenders, resulting in bulk purchases aligned with budget cycles and public health initiatives. Re-exporters' purchasing patterns depend on the demand in their target export markets.

United States

1. Drug Regulatory Authority: U.S. Food and Drug Administration (FDA).

2. Import Registration Process for Torsemide: Importers must ensure that Torsemide is FDA-approved. The process involves submitting an Abbreviated New Drug Application (ANDA) for generic drugs, demonstrating bioequivalence to the brand-name counterpart.

3. Estimated Timeline for Registration: The FDA review process for an ANDA typically takes 10 months, though it can vary based on the completeness of the application and FDA workload.

4. Import Tariff/Duty for HS 30049099: Pharmaceutical products under HS Code 30049099 are generally duty-free in the United States.

Nigeria

1. Drug Regulatory Authority: National Agency for Food and Drug Administration and Control (NAFDAC).

2. Import Registration Process for Torsemide: Importers must register the product with NAFDAC, providing documentation such as a Certificate of Pharmaceutical Product (CPP), Good Manufacturing Practice (GMP) certificate, and samples for laboratory analysis.

3. Estimated Timeline for Registration: The registration process can take approximately 6 to 12 months, depending on the completeness of the submission and NAFDAC's review process.

4. Import Tariff/Duty for HS 30049099: Pharmaceutical products under this HS code are subject to a 5% import duty in Nigeria.

Yemen

1. Drug Regulatory Authority: Supreme Board of Drugs and Medical Appliances (SBDMA).

2. Import Registration Process for Torsemide: Importers are required to submit a registration dossier to the SBDMA, including product samples, manufacturing licenses, and quality certificates.

3. Estimated Timeline for Registration: The registration process typically takes 6 to 9 months, contingent upon the thoroughness of the application and the SBDMA's evaluation procedures.

4. Import Tariff/Duty for HS 30049099: Yemen imposes a 5% import duty on pharmaceutical products classified under this HS code.

Mauritius

1. Drug Regulatory Authority: Pharmacy Board of Mauritius.

2. Import Registration Process for Torsemide: Importers must obtain approval from the Pharmacy Board by submitting a detailed application, including product specifications, manufacturing details, and evidence of registration in the country of origin.

3. Estimated Timeline for Registration: The approval process usually takes between 3 to 6 months, depending on the completeness of the application and the Board's review schedule.

4. Import Tariff/Duty for HS 30049099: Pharmaceuticals under this HS code are generally exempt from import duties in Mauritius.

Sri Lanka

1. Drug Regulatory Authority: National Medicines Regulatory Authority (NMRA).

2. Import Registration Process for Torsemide: Importers are required to register the product with the NMRA, providing comprehensive documentation, including a Certificate of Pharmaceutical Product (CPP), GMP certificate, and product samples.

3. Estimated Timeline for Registration: The registration process can take approximately 6 to 12 months, depending on the completeness of the submission and the NMRA's review process.

4. Import Tariff/Duty for HS 30049099: Sri Lanka imposes a 0% import duty on pharmaceutical products under this HS code.

The demand for Torsemide in importing countries is primarily driven by the prevalence of cardiovascular diseases, particularly heart failure and hypertension, conditions for which Torsemide is commonly prescribed. According to the World Health Organization (WHO), cardiovascular diseases remain the leading cause of death globally, accounting for approximately 17.9 million deaths annually as of 2024. This high disease burden necessitates the availability of effective diuretics like Torsemide.

Government healthcare programs and the expansion of universal health coverage also significantly influence the demand for essential medicines. Many countries have included Torsemide in their national Essential Medicines Lists, aligning with the WHO's Model List of Essential Medicines, which emphasizes the importance of such medications in addressing public health needs. Additionally, procurement through international organizations and tender-based purchasing mechanisms ensures a steady demand. For example, the WHO's Prequalification Programme facilitates the procurement of quality-assured medicines by various countries, thereby supporting consistent demand for drugs like Torsemide. (iris.who.int)

The presence of 232 buyers across 51 countries, with a repeat buyer rate of 64.2%, underscores the sustained global demand for Torsemide. This consistent purchasing pattern reflects the medication's critical role in managing cardiovascular conditions worldwide.

The importers of Torsemide from India can be categorized into several key segments:

1. Distributors: These entities purchase large quantities of Torsemide to supply to various healthcare providers, pharmacies, and retailers within their respective countries. For instance, MICRO NOVA PHARMACEUTICALS IND in Nigeria, which imported Torsemide worth $1.12 million, likely operates as a distributor, ensuring widespread availability of the medication across the Nigerian market.

2. Contract Manufacturers: Companies that import Torsemide for the purpose of further manufacturing or repackaging before distribution. AUROLOGISTICS LLC, associated with AUROBINDO PHARMA in the United States, appears multiple times among the top buyers, with combined imports totaling approximately $2.57 million. This suggests a role in contract manufacturing or distribution within the U.S. pharmaceutical supply chain.

3. Retail Chains and Hospital Groups: While specific data on retail chains and hospital groups is not detailed in the provided information, it's common for such entities to import pharmaceuticals directly to meet the needs of their patients and customers.

4. Government Procurement Agencies: These agencies import medications to supply public healthcare facilities. The data does not specify any government procurement agencies among the top buyers of Torsemide from India.

5. Re-exporters: Companies that import pharmaceuticals with the intention of exporting them to other markets. The data does not provide specific information on re-exporters in the context of Torsemide imports.

Each segment exhibits distinct purchasing behaviors. Distributors and contract manufacturers often place large, recurring orders to maintain a steady supply chain, as evidenced by the 64.2% repeat buyer rate among the 232 buyers. Retail chains and hospital groups may order based on patient demand and inventory levels, leading to variable order sizes and frequencies. Government agencies typically procure through tenders, resulting in bulk purchases aligned with budget cycles and public health initiatives. Re-exporters' purchasing patterns depend on the demand in their target export markets.

United States

1. Drug Regulatory Authority: U.S. Food and Drug Administration (FDA).

2. Import Registration Process for Torsemide: Importers must ensure that Torsemide is FDA-approved. The process involves submitting an Abbreviated New Drug Application (ANDA) for generic drugs, demonstrating bioequivalence to the brand-name counterpart.

3. Estimated Timeline for Registration: The FDA review process for an ANDA typically takes 10 months, though it can vary based on the completeness of the application and FDA workload.

4. Import Tariff/Duty for HS 30049099: Pharmaceutical products under HS Code 30049099 are generally duty-free in the United States.

Nigeria

1. Drug Regulatory Authority: National Agency for Food and Drug Administration and Control (NAFDAC).

2. Import Registration Process for Torsemide: Importers must register the product with NAFDAC, providing documentation such as a Certificate of Pharmaceutical Product (CPP), Good Manufacturing Practice (GMP) certificate, and samples for laboratory analysis.

3. Estimated Timeline for Registration: The registration process can take approximately 6 to 12 months, depending on the completeness of the submission and NAFDAC's review process.

4. Import Tariff/Duty for HS 30049099: Pharmaceutical products under this HS code are subject to a 5% import duty in Nigeria.

Yemen

1. Drug Regulatory Authority: Supreme Board of Drugs and Medical Appliances (SBDMA).

2. Import Registration Process for Torsemide: Importers are required to submit a registration dossier to the SBDMA, including product samples, manufacturing licenses, and quality certificates.

3. Estimated Timeline for Registration: The registration process typically takes 6 to 9 months, contingent upon the thoroughness of the application and the SBDMA's evaluation procedures.

4. Import Tariff/Duty for HS 30049099: Yemen imposes a 5% import duty on pharmaceutical products classified under this HS code.

Mauritius

1. Drug Regulatory Authority: Pharmacy Board of Mauritius.

2. Import Registration Process for Torsemide: Importers must obtain approval from the Pharmacy Board by submitting a detailed application, including product specifications, manufacturing details, and evidence of registration in the country of origin.

3. Estimated Timeline for Registration: The approval process usually takes between 3 to 6 months, depending on the completeness of the application and the Board's review schedule.

4. Import Tariff/Duty for HS 30049099: Pharmaceuticals under this HS code are generally exempt from import duties in Mauritius.

Sri Lanka

1. Drug Regulatory Authority: National Medicines Regulatory Authority (NMRA).

2. Import Registration Process for Torsemide: Importers are required to register the product with the NMRA, providing comprehensive documentation, including a Certificate of Pharmaceutical Product (CPP), GMP certificate, and product samples.

3. Estimated Timeline for Registration: The registration process can take approximately 6 to 12 months, depending on the completeness of the submission and the NMRA's review process.

4. Import Tariff/Duty for HS 30049099: Sri Lanka imposes a 0% import duty on pharmaceutical products under this HS code.

The demand for Torsemide in importing countries is primarily driven by the prevalence of cardiovascular diseases, particularly heart failure and hypertension, conditions for which Torsemide is commonly prescribed. According to the World Health Organization (WHO), cardiovascular diseases remain the leading cause of death globally, accounting for approximately 17.9 million deaths annually as of 2024. This high disease burden necessitates the availability of effective diuretics like Torsemide.

Government healthcare programs and the expansion of universal health coverage also significantly influence the demand for essential medicines. Many countries have included Torsemide in their national Essential Medicines Lists, aligning with the WHO's Model List of Essential Medicines, which emphasizes the importance of such medications in addressing public health needs. Additionally, procurement through international organizations and tender-based purchasing mechanisms ensures a steady demand. For example, the WHO's Prequalification Programme facilitates the procurement of quality-assured medicines by various countries, thereby supporting consistent demand for drugs like Torsemide. (iris.who.int)

The presence of 232 buyers across 51 countries, with a repeat buyer rate of 64.2%, underscores the sustained global demand for Torsemide. This consistent purchasing pattern reflects the medication's critical role in managing cardiovascular conditions worldwide.